JAMP POMALIDOMIDE
JAMP POMALIDOMIDE
Approved
DIN Number
02538059
Drug Class
Human
Market Date
Aug 1, 2023
Company
HC
Jamp Pharma Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02538059
AIG Number0155290001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L04AX06 POMALIDOMIDE
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
POMALIDOMIDEActive
Strength: 1 MG
Monograph: POMALIDOMIDE